Neuberger Berman Group LLC increased its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 1.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 501,562 shares of the company's stock after acquiring an additional 5,809 shares during the quarter. Neuberger Berman Group LLC owned approximately 3.33% of Chemed worth $265,726,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also bought and sold shares of CHE. UMB Bank n.a. increased its holdings in Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares during the period. Atala Financial Inc purchased a new position in shares of Chemed during the fourth quarter valued at approximately $29,000. CBIZ Investment Advisory Services LLC raised its holdings in shares of Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after acquiring an additional 22 shares in the last quarter. Trust Co. of Vermont purchased a new stake in Chemed in the fourth quarter worth $34,000. Finally, Tortoise Investment Management LLC boosted its holdings in Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after acquiring an additional 34 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 3.32% of the stock is currently owned by insiders.
Chemed Trading Down 1.3 %
CHE traded down $8.03 during trading on Tuesday, reaching $592.66. The stock had a trading volume of 55,559 shares, compared to its average volume of 97,105. The company has a market capitalization of $8.66 billion, a price-to-earnings ratio of 29.95, a P/E/G ratio of 2.15 and a beta of 0.49. The stock's 50 day moving average is $583.92 and its two-hundred day moving average is $567.73. Chemed Co. has a one year low of $512.12 and a one year high of $625.09.
Chemed Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed's dividend payout ratio (DPR) is currently 10.05%.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the stock. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada lifted their price objective on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research report on Friday, March 14th.
Check Out Our Latest Stock Report on Chemed
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Further Reading

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.